Klinik und Hochschulambulanz für Neurologie, Charite Universitatsmedizin Berlin, Berlin, Germany
Center for Stroke Research Berlin (CSB), Charite Universitatsmedizin Berlin, Berlin, Germany.
J Neurointerv Surg. 2023 Nov;15(e2):e216-e222. doi: 10.1136/jnis-2022-019365. Epub 2022 Nov 1.
Thrombus migration (TM) is frequently observed in large vessel occlusion (LVO) ischemic stroke to be treated by endovascular thrombectomy (EVT). TM may impede complete recanalization and hereby worsen clinical outcomes. This study aimed to delineate factors associated with TM and clarify its impact on technical and functional outcome.
All patients undergoing EVT due to LVO in the anterior circulation at two tertiary stroke centers between October 2015 and December 2020 were included. Source imaging data of all individuals were assessed regarding occurrence of TM by raters blinded to clinical data. Patient data were gathered as part of the German Stroke Registry, a multicenter, prospective registry assessing real-world outcomes. Technical outcome was assessed by modified Thrombolysis in Cerebral Infarction scale (mTICI). Functional outcome was assessed by modified Rankin Scale (mRS) at 3 months.
The study consisted of 512 individuals, of which 71 (13.8%) displayed TM. In adjusted analyses, TM was associated with longer time from primary imaging to reassessment in the angio suite (aOR 2.37 (1.47 to 3.84) per logarithmic step) and intravenous thrombolysis (IVT; aOR 4.07 (2.17 to 7.65)). In individuals with IVT, a needle-to-groin time >1 hour was associated with higher odds for TM (aOR 2.60 (1.20 to 5.99)). TM was associated with lack of complete recanalization (aOR 0.46 (0.24 to 0.90)) but TM did not worsen odds for good clinical outcome (aOR 0.89 (0.47 to 1.68)).
TM is associated with IVT and longer time between sequential assessments of thrombus location. Consequently, TM may be of high relevance in patients with drip-and-ship treatment.
血栓迁移(TM)在接受血管内血栓切除术(EVT)治疗的大血管闭塞(LVO)缺血性卒中中经常观察到。TM 可能会阻碍完全再通,并因此恶化临床结果。本研究旨在描述与 TM 相关的因素,并阐明其对技术和功能结果的影响。
纳入 2015 年 10 月至 2020 年 12 月在两个三级卒中中心因前循环 LVO 接受 EVT 的所有患者。所有患者的源图像数据均由对临床数据不知情的评估者评估 TM 的发生情况。患者数据作为德国卒中登记处的一部分收集,该登记处是一个多中心、前瞻性登记处,评估真实世界的结果。技术结果通过改良脑梗死溶栓量表(mTICI)评估。功能结果通过 3 个月时的改良 Rankin 量表(mRS)评估。
该研究共纳入 512 例患者,其中 71 例(13.8%)存在 TM。在调整分析中,TM 与从初始影像学检查到血管造影室再次评估的时间较长相关(对数步长的比值比 2.37[1.47 至 3.84])和静脉溶栓(IVT;比值比 4.07[2.17 至 7.65])。在接受 IVT 的患者中,针至腹股沟时间>1 小时与 TM 发生的几率更高相关(比值比 2.60[1.20 至 5.99])。TM 与不完全再通相关(比值比 0.46[0.24 至 0.90]),但 TM 并未降低临床结果良好的几率(比值比 0.89[0.47 至 1.68])。
TM 与 IVT 和血栓位置的连续评估之间的时间较长相关。因此,TM 在滴注和转运治疗的患者中可能具有重要意义。